order by phone 866-930-6790

PDGFR

8 Item(s)

per page
Set Descending Direction

  • CP-673451

    A11350 CP-673451

    CP 673451 is a potent PDGFR-β inhibitor with an IC50 of 1 nM.
  • Crenolanib (CP-868596)

    A11052 Crenolanib (CP-868596)

    Crenolanib (CP-868596) is an orally bioavailable, selective small molecule inhibitor of the PDGFR tyrosine kinase, inhibiting both PDGFRA and PDGFRB at picomolar concentrations.
  • Delphinidin chloride

    A11978 Delphinidin chloride

    Delphinidin chloride is an anthocyanidin, a common plant pigment, found in pigmented fruits and vegetable.
  • KRN 633

    A10504 KRN 633

    KRN 633 is a cell-permeable, reversible, ATP-competitive VEGFR kinase inhibitor that inhibits PDGFR-α and c-Kit at higher concentrations only (IC50 = 0.97 μM and 4.33 μM, respectively) and inactive towards 17 other kinases (IC50 ≥ 10 μM).
  • MK-2461

    A11753 MK-2461

    MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor.
  • Sunitinib Malate

    A10880 Sunitinib Malate

    Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).
  • Telatinib (BAY 57-9352)

    A10903 Telatinib (BAY 57-9352)

    Telatinib (BAY 57-9352) is an orally available, small-molecule inhibitor of vascular endothelial growth factor receptors 2 and 3 (VEGFR-2/-3) and platelet-derived growth factor receptor β tyrosine kinases.
  • Toceranib (PHA 291639, SU 11654)

    A11581 Toceranib (PHA 291639, SU 11654)

    Toceranib is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.

8 Item(s)

per page
Set Descending Direction